English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

This work aimed to develop controlled-release lipid-based formulations of microemulsion-loaded oleogels for the oral delivery of the poorly soluble drug carvedilol (CARV). The microemulsion-loaded oleogels were prepared by the oleogelator Compritol® 888 (CP888). CARV was loaded into submicron-sized emulsions (CARV-MEs) of various ratios of surfactant and cosurfactant. The CARV-MEs were entrapped into CP888-based oleogels, forming CARV-ME oleogels. The rheological properties and dissolution studies of the CARV-ME oleogels were determined. MTT assay test was performed to ensure the safety of oleogel formulations. The optimized formulation of CARV-ME oleogel was subjected to stability studies. The results revealed that CARV-MEs were thermodynamically stable of spherical globules of average size 13.3–57.4 nm, polydispersity index (PDI) range of 0.24–0.52, and interfacial tension of 29.9 ± 0.2 mN/m. Oleogels exhibited viscoelastic properties with more elastic behavior. The drug release rate was found to be dependent on the surfactant/cosurfactant ratio. A negative correlation was found between surfactant concentration and IC 50 . The optimized CARV-MEs oleogel was stable for 3 months at various storage conditions. In conclusion, the entrapment of the CARV-MEs, with various surfactant to cosurfactant ratios, into oleogels influences the dissolution rate and mechanism of drug release and the safety of CARV-MEs oleogels.

Lipid-based formulations of microemulsion-loaded oleogels for the oral delivery of carvedilol